RELATED CONTENT
NEWS
- US FDA reviewers: Efficacy data analyses for Pharmaxis CF drug 'problematic'
- Pharmaxis tumbles on FDA rejection of Bronchitol in CF
- NICE OKs Pharmaxis and Novartis drugs but not Forest's colistimethate in CF patients
- Pharmaxis cuts 30% of jobs following FDA's Bronchitol rejection
EVENTS
17 September 2013
Radisson BLU, Berlin, Germany
18 September 2013
London, UK
16 October 2013
London, UK
JOB OF THE WEEK
Our latest jobs

